| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_imr90ipsc_promoter_p_RM_14_20_3 |
 |
 |
3 |
0.4 |
3.54E-04 |
SQRDL,
GPD1L |
glycerol-3-phosphate catabolic process [BP],
negative regulation of protein kinase C signaling cascade [BP],
sulfide:quinone oxidoreductase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_162_6 |
 |
 |
4 |
0.8 |
2.74E-04 |
HLA-F,
HLA-A |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP],
MHC class I protein complex [CC],
ER to Golgi transport vesicle membrane [CC],
integral to lumenal side of endoplasmic reticulum membrane [CC],
MHC class I receptor activity [MF] |
| CG_imr90ipsc_promoter_p_RM_16_4_2 |
 |
 |
9 |
1.0 |
6.19E-04 |
NTRK2,
FMN2,
SOX8 |
meiotic chromosome movement towards spindle pole [BP],
oligodendrocyte differentiation [BP],
brain-derived neurotrophic factor binding [MF],
peripheral nervous system development [BP],
cerebral cortex development [BP],
brain-derived neurotrophic factor-activated receptor activity [MF],
brain-derived neurotrophic factor receptor signaling pathway [BP] |
| CG_imr90ipsc_promoter_p_RM_14_13_1 |
 |
 |
3 |
0.4 |
3.63E-04 |
PHF2,
GIPR |
gastric inhibitory peptide receptor activity [MF],
negative regulation of chromatin silencing at rDNA [BP] |
| CG_imr90ipsc_promoter_p_RM_12_177_4 |
 |
 |
4 |
0.8 |
2.48E-04 |
ATP2A2,
PAK2,
CDH13 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [BP],
calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF],
adiponectin binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_96_4 |
 |
 |
5 |
0.8 |
1.78E-04 |
SHROOM2 |
eye pigment granule organization [BP] |
| CG_imr90ipsc_promoter_p_RM_12_43_5 |
 |
 |
2 |
0.4 |
3.50E-04 |
SLC50A1 |
glucoside transport [BP],
glucoside transmembrane transporter activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_236_6 |
 |
 |
4 |
0.8 |
2.18E-04 |
SPHK1,
EIF4EBP1,
NADSYN1,
TIRAP,
CD4 |
positive regulation of chemokine (C-X-C motif) ligand 1 production [BP],
induction by virus of host cell-cell fusion [BP],
positive regulation of interleukin-15 production [BP],
TIRAP-dependent toll-like receptor 4 signaling pathway [BP],
positive regulation of mitotic cell cycle [BP],
sphingoid catabolic process [BP],
NAD+ synthase (glutamine-hydrolyzing) activity [MF],
Toll-like receptor 2 binding [MF],
protein palmitoleylation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_94_8 |
 |
 |
4 |
0.8 |
3.78E-04 |
RAC1,
PACSIN1,
CHST7,
RTN3,
USO1 |
Golgi membrane [CC],
negative regulation of endocytosis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_45_8 |
 |
 |
4 |
0.6 |
3.86E-04 |
RNF4 |
progesterone receptor binding [MF],
regulation of kinetochore assembly [BP] |
| CG_imr90ipsc_promoter_p_RM_12_160_6 |
 |
 |
5 |
0.8 |
3.62E-04 |
ARF6,
FMNL2 |
cortical actin cytoskeleton organization [BP] |
| CG_imr90ipsc_promoter_p_RM_12_65_10 |
 |
 |
5 |
1.0 |
2.33E-04 |
BTRC,
MSX2 |
branching involved in mammary gland duct morphogenesis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_72_10 |
 |
 |
2 |
0.4 |
2.67E-04 |
MICA,
ALPL,
MICB |
natural killer cell lectin-like receptor binding [MF],
cementum mineralization [BP],
immune response-activating cell surface receptor signaling pathway [BP],
MHC class I protein complex [CC],
gamma-delta T cell activation [BP],
cytolysis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_201_4 |
 |
 |
4 |
0.8 |
2.10E-04 |
SLC6A8,
INPPL1,
SQSTM1 |
creatine transmembrane transporter activity [MF],
SH2 domain binding [MF],
creatine transport [BP],
creatine:sodium symporter activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_179_2 |
 |
 |
4 |
0.8 |
2.94E-04 |
SDHAF1 |
mitochondrial respiratory chain complex II assembly [BP] |
| CG_imr90ipsc_promoter_p_RM_12_70_9 |
 |
 |
5 |
0.8 |
2.97E-04 |
ARPC2,
CYP1A2,
SAMM50,
DISP1 |
oxidative deethylation [BP],
mitochondrial sorting and assembly machinery complex [CC],
Arp2/3 complex binding [MF],
patched ligand maturation [BP],
AP-1 adaptor complex binding [MF],
toxin biosynthetic process [BP] |
| CG_imr90ipsc_promoter_p_RM_12_229_7 |
 |
 |
6 |
1.0 |
1.98E-04 |
SNCAIP,
NTRK2,
NIPBL |
regulation of neurotransmitter secretion [BP],
cognition [BP],
brain-derived neurotrophic factor-activated receptor activity [MF],
brain-derived neurotrophic factor receptor signaling pathway [BP],
brain-derived neurotrophic factor binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_152_8 |
 |
 |
5 |
0.6 |
7.03E-05 |
NTMT1 |
N-terminal peptidyl-alanine trimethylation [BP],
N-terminal peptidyl-serine trimethylation [BP],
N-terminal peptidyl-serine dimethylation [BP],
N-terminal peptidyl-proline dimethylation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_29_3 |
 |
 |
4 |
0.8 |
2.71E-04 |
PLEKHF1,
LANCL2 |
phosphatidylinositol-3-phosphate binding [MF],
phosphatidylinositol-5-phosphate binding [MF],
positive regulation of abscisic acid mediated signaling pathway [BP],
phosphatidylinositol-4-phosphate binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_175_7 |
 |
 |
5 |
1.0 |
2.02E-04 |
THTPA,
PANX1,
SC5DL,
NLGN1,
TAF1B |
neurexin clustering [BP],
positive regulation of synaptic vesicle endocytosis [BP],
RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity [MF],
thiamin-triphosphatase activity [MF],
RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [BP],
leak channel activity [MF],
lathosterol oxidase activity [MF],
RNA polymerase I CORE element sequence-specific DNA binding [MF],
cholesterol biosynthetic process via lathosterol [BP],
cytoskeletal matrix organization at active zone [BP],
RNA polymerase I core factor complex [CC],
positive regulation of synaptic vesicle exocytosis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_53_2 |
 |
 |
5 |
0.8 |
2.64E-04 |
ACR,
POMT1 |
acrosomal vesicle [CC],
acrosome matrix dispersal [BP],
amidase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_73_4 |
 |
 |
6 |
1.0 |
2.70E-04 |
MTRR,
DHRS4 |
alcohol dehydrogenase [NAD(P)+] activity [MF],
[methionine synthase] reductase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_49_8 |
 |
 |
7 |
1.0 |
2.83E-04 |
YKT6,
EXOC6 |
vesicle docking involved in exocytosis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_55_2 |
 |
 |
4 |
0.8 |
2.81E-04 |
NDOR1,
ST8SIA2,
CTF1,
TMOD2,
FLVCR1 |
heme export [BP],
cellular response to menadione [BP],
nervous system development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_150_5 |
 |
 |
5 |
0.8 |
2.75E-04 |
ADHFE1,
DNM1L |
hydroxyacid-oxoacid transhydrogenase activity [MF],
dynamin polymerization involved in mitochondrial fission [BP],
membrane fission involved in mitochondrial fission [BP] |
| CG_imr90ipsc_promoter_p_RM_12_51_3 |
 |
 |
4 |
0.8 |
4.06E-04 |
ACR,
PLK3,
DAB2IP,
PAX2,
CBLC |
negative regulation of epidermal growth factor receptor signaling pathway [BP],
vestibulocochlear nerve formation [BP],
positive regulation of optic nerve formation [BP],
optic chiasma development [BP],
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [BP],
acrosome matrix dispersal [BP],
cellular response to epidermal growth factor stimulus [BP] |
| CG_imr90ipsc_promoter_p_RM_12_228_8 |
 |
 |
7 |
1.0 |
3.48E-04 |
NDOR1,
CAMK1D,
NDUFV1,
SOX8,
TBX1,
VEGFA,
QKI |
cell death [BP],
muscle cell differentiation [BP],
FMN binding [MF],
coronary artery morphogenesis [BP],
positive regulation of branching involved in ureteric bud morphogenesis [BP],
positive regulation of CREB transcription factor activity [BP],
lymph vessel development [BP],
regulation of organ morphogenesis [BP] |
| CG_imr90ipsc_promoter_p_RM_14_8_2 |
 |
 |
3 |
0.6 |
5.55E-04 |
DAO |
proline catabolic process [BP],
D-serine metabolic process [BP],
D-alanine catabolic process [BP],
D-serine catabolic process [BP],
D-amino-acid oxidase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_42_15 |
 |
 |
4 |
0.8 |
3.54E-04 |
EGR1,
CREBL2,
MAP2K5,
CDC73,
HEY2,
FOXG1,
NOG,
MEIS1,
USF2,
DISP1,
ARRDC2,
IL11RA,
NKX2-3,
GNAI2,
TGIF1,
EPAS1 |
dorsal/ventral pattern formation [BP],
sequence-specific DNA binding [MF],
positive regulation of transcription from RNA polymerase II promoter [BP],
signal transduction [BP] |
| CG_imr90ipsc_promoter_p_RM_12_168_3 |
 |
 |
6 |
0.8 |
2.92E-04 |
PARPBP |
negative regulation of double-strand break repair via homologous recombination [BP] |
| CG_imr90ipsc_promoter_p_RM_12_238_8 |
 |
 |
5 |
1.0 |
2.16E-04 |
CTNNA1,
GATA4 |
establishment or maintenance of cell polarity [BP],
lung lobe formation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_171_8 |
 |
 |
5 |
0.8 |
2.93E-04 |
NAB1 |
myelination [BP] |
| CG_imr90ipsc_promoter_p_RM_12_227_12 |
 |
 |
7 |
1.0 |
3.24E-04 |
BMS1,
NIP7 |
ribosome assembly [BP] |
| CG_imr90ipsc_promoter_p_RM_12_169_8 |
 |
 |
5 |
1.0 |
2.16E-04 |
PGS1,
MAVS |
CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF],
positive regulation of IP-10 production [BP] |
| CG_imr90ipsc_promoter_p_RM_12_2_11 |
 |
 |
5 |
1.0 |
3.66E-04 |
SIRT1,
RAD23A,
USP1,
UBE2L3,
PPIA,
UBR3,
ADIPOQ,
PRKCI |
ubiquitin-dependent protein catabolic process [BP],
positive regulation of cholesterol efflux [BP],
establishment or maintenance of epithelial cell apical/basal polarity [BP],
positive regulation of viral genome replication [BP],
establishment of apical/basal cell polarity [BP],
positive regulation of cAMP-dependent protein kinase activity [BP] |
| CG_imr90ipsc_promoter_p_RM_12_140_4 |
 |
 |
2 |
0.4 |
2.46E-04 |
NANOS3,
SOX9,
BFAR,
CDKN1A,
EPO |
response to hyperoxia [BP],
negative regulation of apoptotic process [BP] |
| CG_imr90ipsc_promoter_p_RM_12_154_4 |
 |
 |
3 |
0.6 |
3.69E-04 |
ATOH1,
B4GALT7 |
positive regulation of auditory receptor cell differentiation [BP],
xylosylprotein 4-beta-galactosyltransferase activity [MF],
auditory receptor cell fate specification [BP] |
| CG_imr90ipsc_promoter_p_RM_12_66_10 |
 |
 |
7 |
1.0 |
2.04E-04 |
BAIAP2,
FGD5 |
filopodium assembly [BP] |
| CG_imr90ipsc_promoter_p_RM_12_192_6 |
 |
 |
4 |
0.8 |
2.52E-04 |
BCL2L11 |
BIM-BCL-2 complex [CC],
BIM-BCL-xl complex [CC] |
| CG_imr90ipsc_promoter_p_RM_12_219_7 |
 |
 |
7 |
1.0 |
2.49E-04 |
RAD23B,
DMBX1,
BIRC5,
PPARD,
KAT6B,
NACC1,
FGF2,
PRPF6,
RARA |
nucleoplasm [CC],
negative regulation of transcription, DNA-dependent [BP],
chondroblast differentiation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_14_7 |
 |
 |
4 |
0.8 |
3.47E-04 |
CHD7,
FOXG1 |
nose development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_46_7 |
 |
 |
6 |
1.0 |
1.72E-04 |
LHX9,
BCL2L11,
RBM38,
BUB3,
GATA6 |
male gonad development [BP],
regulation of chromosome segregation [BP],
cell cycle [BP] |
| CG_imr90ipsc_promoter_p_RM_12_7_6 |
 |
 |
5 |
0.8 |
1.47E-04 |
CBR1,
FMN2,
AGBL5 |
protein branching point deglutamylation [BP],
meiotic chromosome movement towards spindle pole [BP],
prostaglandin-E2 9-reductase activity [MF],
15-hydroxyprostaglandin dehydrogenase (NADP+) activity [MF],
oogenesis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_167_4 |
 |
 |
3 |
0.6 |
2.09E-04 |
SOX11,
HES1,
FBXW8 |
glial cell proliferation [BP],
negative regulation of glial cell proliferation [BP],
labyrinthine layer blood vessel development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_59_9 |
 |
 |
5 |
0.8 |
3.75E-04 |
NKX2-3 |
post-embryonic digestive tract morphogenesis [BP],
plasma cell differentiation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_165_5 |
 |
 |
5 |
0.8 |
1.83E-04 |
HEY2,
ASNA1,
GAA,
PRPF31 |
detoxification of arsenic-containing substance [BP],
diaphragm contraction [BP],
U4 snRNP [CC],
sucrose metabolic process [BP],
snRNP binding [MF],
U4atac snRNP [CC],
ventricular cardiac muscle tissue morphogenesis [BP],
maltose metabolic process [BP],
vacuolar sequestering [BP],
negative regulation of cardiac vascular smooth muscle cell differentiation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_190_6 |
 |
 |
3 |
0.6 |
2.72E-04 |
FGF9,
DMRT1 |
male gonad development [BP],
male sex differentiation [BP],
sex determination [BP],
Sertoli cell differentiation [BP],
male sex determination [BP] |
| CG_imr90ipsc_promoter_p_RM_12_226_5 |
 |
 |
2 |
0.4 |
2.14E-04 |
GPD1L,
GATA6 |
type B pancreatic cell differentiation [BP],
negative regulation of transforming growth factor beta2 production [BP],
negative regulation of protein kinase C signaling cascade [BP] |
| CG_imr90ipsc_promoter_p_RM_12_67_3 |
 |
 |
5 |
1.0 |
4.03E-04 |
GIPR |
gastric inhibitory peptide receptor activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_134_7 |
 |
 |
6 |
0.8 |
5.78E-04 |
SIVA1 |
CD27 receptor binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_222_2 |
 |
 |
6 |
0.8 |
2.85E-04 |
ENGASE,
IL6R |
ciliary neurotrophic factor binding [MF],
mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_77_3 |
 |
 |
3 |
0.6 |
1.86E-04 |
EMG1,
MTO1,
COL14A1 |
mitochondrial tRNA wobble uridine modification [BP],
rRNA (pseudouridine) methyltransferase activity [MF],
collagen type XIV [CC] |
| CG_imr90ipsc_promoter_p_RM_12_209_11 |
 |
 |
5 |
1.0 |
3.85E-04 |
CNTNAP1,
NEFM |
axon cargo transport [BP] |
| CG_imr90ipsc_promoter_p_RM_12_163_7 |
 |
 |
6 |
0.8 |
4.00E-04 |
RGCC,
FOS |
R-SMAD binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_151_3 |
 |
 |
2 |
0.4 |
2.54E-04 |
BHLHE22,
SLC30A9,
FGF9,
SLC25A26,
DMTF1,
TCF7 |
chromatin binding [MF],
S-adenosyl-L-methionine transport [BP],
embryonic digestive tract development [BP],
S-adenosyl-L-methionine transmembrane transporter activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_158_3 |
 |
 |
2 |
0.4 |
4.45E-04 |
KHDRBS1,
TCF7L1,
LANCL2 |
Grb2-Sos complex [CC],
positive regulation of abscisic acid mediated signaling pathway [BP],
positive regulation of transcription from RNA polymerase II promoter during mitosis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_79_4 |
 |
 |
4 |
0.8 |
1.48E-04 |
LTBP4,
AIP,
BMPR1B |
transmembrane receptor protein serine/threonine kinase activity [MF],
GAF domain binding [MF],
transforming growth factor beta-activated receptor activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_224_7 |
 |
 |
5 |
0.8 |
4.34E-04 |
NTMT1,
RAD23B |
N-terminal peptidyl-alanine trimethylation [BP],
N-terminal peptidyl-serine trimethylation [BP],
N-terminal peptidyl-serine dimethylation [BP],
nucleotide-excision repair, DNA damage recognition [BP],
N-terminal peptidyl-proline dimethylation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_161_4 |
 |
 |
7 |
0.8 |
3.74E-04 |
SOX11,
F2R,
BASP1,
DNM1L,
PAX2,
EDNRA,
MAVS,
ACVR2B |
glomerular filtration [BP],
positive regulation of release of sequestered calcium ion into cytosol [BP],
kidney development [BP],
optic cup morphogenesis involved in camera-type eye development [BP],
metanephric mesenchyme development [BP],
pancreas development [BP],
elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway [BP],
urogenital system development [BP],
regulation of peroxisome organization [BP],
camera-type eye development [BP],
mesenchymal to epithelial transition [BP],
positive regulation of kidney development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_16_9 |
 |
 |
6 |
0.8 |
2.75E-04 |
CAPN10 |
positive regulation of intracellular transport [BP] |
| CG_imr90ipsc_promoter_p_RM_12_54_4 |
 |
 |
4 |
0.8 |
2.16E-04 |
MTDH,
DNAJA3 |
NF-kappaB binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_153_2 |
 |
 |
4 |
0.6 |
2.72E-04 |
NT5E,
MOG,
IKZF1 |
positive regulation of neutrophil differentiation [BP],
adenosine biosynthetic process [BP],
positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP] |
| CG_imr90ipsc_promoter_p_RM_12_76_7 |
 |
 |
5 |
1.0 |
1.99E-04 |
AGK,
FPGS,
GCDH,
PHPT1 |
glutaryl-CoA dehydrogenase activity [MF],
peptidyl-histidine dephosphorylation [BP],
tetrahydrofolylpolyglutamate synthase activity [MF],
acylglycerol kinase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_20_5 |
 |
 |
6 |
1.0 |
4.20E-04 |
TET2,
BCL2L11,
SLIT2,
CRIM1,
KIF2A |
kidney development [BP],
negative regulation of actin filament polymerization [BP],
nervous system development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_1_8 |
 |
 |
5 |
0.8 |
2.18E-04 |
WDYHV1,
GDF7,
NUP85,
SH2B1,
SPAG6 |
roof plate formation [BP],
cell projection organization [BP],
lamellipodium assembly [BP],
positive regulation of tendon cell differentiation [BP],
protein-N-terminal glutamine amidohydrolase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_211_7 |
 |
 |
2 |
0.4 |
3.41E-04 |
ENOPH1 |
acireductone synthase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_28_4 |
 |
 |
2 |
0.4 |
7.43E-05 |
LSM11,
ITPA |
ITP catabolic process [BP],
U7 snRNA binding [MF] |
| CG_imr90ipsc_promoter_p_RM_14_15_2 |
 |
 |
7 |
1.0 |
4.94E-04 |
PPIA,
RAD23A,
ACADS |
butyrate catabolic process [BP],
positive regulation of viral genome replication [BP],
butyryl-CoA dehydrogenase activity [MF],
uncoating of virus [BP],
regulation of viral genome replication [BP] |
| CG_imr90ipsc_promoter_p_RM_12_220_6 |
 |
 |
5 |
1.0 |
2.86E-04 |
MGAT2,
PRKAR2B,
CREBRF |
response to antipsychotic drug [BP],
alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF],
negative regulation of endoplasmic reticulum unfolded protein response [BP] |
| CG_imr90ipsc_promoter_p_RM_12_234_6 |
 |
 |
4 |
0.8 |
3.00E-04 |
PAPSS2,
NEU4 |
adenylylsulfate kinase activity [MF],
exo-alpha-(2->3)-sialidase activity [MF],
sulfate adenylyltransferase (ATP) activity [MF],
exo-alpha-(2->6)-sialidase activity [MF],
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [BP],
sulfate assimilation [BP],
exo-alpha-(2->8)-sialidase activity [MF],
exo-alpha-sialidase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_26_6 |
 |
 |
3 |
0.6 |
2.31E-04 |
GCDH,
TRRAP,
ADHFE1,
USP16 |
glutaryl-CoA dehydrogenase activity [MF],
histone deubiquitination [BP],
hydroxyacid-oxoacid transhydrogenase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_184_8 |
 |
 |
4 |
0.8 |
1.92E-04 |
CHRD,
MYCN |
positive regulation of mesenchymal cell proliferation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_213_5 |
 |
 |
4 |
0.8 |
4.17E-04 |
MGAT2,
FOXF1,
MMP14 |
embryonic ectodermal digestive tract morphogenesis [BP],
alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF],
lateral mesodermal cell differentiation [BP],
right lung morphogenesis [BP],
respiratory tube development [BP],
detection of wounding [BP],
mesenchyme migration [BP],
lung development [BP],
smoothened signaling pathway [BP],
negative regulation of mast cell degranulation [BP],
branching involved in open tracheal system development [BP],
branching morphogenesis of an epithelial tube [BP] |
| CG_imr90ipsc_promoter_p_RM_12_141_5 |
 |
 |
2 |
0.4 |
1.65E-04 |
FOXF1,
SNX9 |
embryonic ectodermal digestive tract morphogenesis [BP],
detection of wounding [BP],
mesenchyme migration [BP],
lipid tube assembly [BP],
branching involved in open tracheal system development [BP],
right lung morphogenesis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_111_7 |
 |
 |
3 |
0.6 |
1.31E-04 |
MERTK |
rhabdomere [CC] |
| CG_imr90ipsc_promoter_p_RM_12_130_3 |
 |
 |
3 |
0.6 |
1.40E-04 |
MERTK,
NAGS |
acetyl-CoA:L-glutamate N-acetyltransferase activity [MF],
rhabdomere [CC] |
| CG_imr90ipsc_promoter_p_RM_12_232_7 |
 |
 |
7 |
1.0 |
5.33E-04 |
MTHFD2 |
methylenetetrahydrofolate dehydrogenase (NADP+) activity [MF],
methylenetetrahydrofolate dehydrogenase (NAD+) activity [MF],
methenyltetrahydrofolate cyclohydrolase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_50_2 |
 |
 |
4 |
0.8 |
2.90E-04 |
TLR2 |
chloramphenicol transport [BP],
triacyl lipopeptide binding [MF],
cell surface pattern recognition receptor signaling pathway [BP],
induction by symbiont of defense-related host nitric oxide production [BP] |
| CG_imr90ipsc_promoter_p_RM_12_239_4 |
 |
 |
5 |
0.8 |
2.53E-04 |
CACNA1G,
SLC1A4 |
hydroxyproline transport [BP],
L-hydroxyproline transmembrane transporter activity [MF],
response to nickel cation [BP],
threonine transport [BP],
L-threonine transmembrane transporter activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_30_5 |
 |
 |
4 |
0.6 |
1.72E-04 |
HHEX,
FOXI2,
YAP1,
GPT |
vasculogenesis [BP],
L-alanine:2-oxoglutarate aminotransferase activity [MF],
hepatoblast differentiation [BP],
hepatic duct development [BP],
embryonic organ development [BP],
positive regulation of Wnt receptor signaling pathway [BP],
embryonic heart tube development [BP],
DNA binding, bending [MF] |
| CG_imr90ipsc_promoter_p_RM_12_117_3 |
 |
 |
2 |
0.4 |
4.95E-04 |
NR2F2,
ST3GAL3 |
N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF],
radial pattern formation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_155_3 |
 |
 |
8 |
1.0 |
3.84E-04 |
FOXL1,
FOXD3,
PDE3B,
GATA4 |
regulation of insulin secretion [BP],
RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF],
glucose homeostasis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_143_3 |
 |
 |
6 |
0.8 |
3.08E-04 |
DOCK1,
EMX2,
SHROOM2 |
eye pigment granule organization [BP],
phagocytosis, engulfment [BP],
forebrain cell migration [BP] |
| CG_imr90ipsc_promoter_p_RM_12_89_4 |
 |
 |
4 |
0.8 |
2.63E-04 |
AFAP1L1,
CA2,
TYMS,
ADC,
PLEKHO2,
FEM1B,
ARHGEF12 |
arginine decarboxylase activity [MF],
branching involved in prostate gland morphogenesis [BP],
phospholipid binding [MF],
immortalization of host cell by virus [BP],
thymidylate synthase activity [MF],
dTMP biosynthetic process [BP],
morphogenesis of an epithelium [BP] |
| CG_imr90ipsc_promoter_p_RM_12_126_7 |
 |
 |
3 |
0.6 |
4.06E-04 |
EID1,
MPG |
histone acetyltransferase regulator activity [MF],
DNA-7-methylguanine glycosylase activity [MF],
DNA-3-methylguanine glycosylase activity [MF],
DNA-3-methyladenine glycosylase activity [MF],
DNA-7-methyladenine glycosylase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_19_4 |
 |
 |
4 |
0.6 |
3.65E-04 |
GIPR,
MSMO1 |
gastric inhibitory peptide receptor activity [MF],
C-4 methylsterol oxidase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_56_6 |
 |
 |
4 |
0.6 |
3.32E-04 |
PRKCE,
DRAXIN,
TCAP |
titin Z domain binding [MF],
TRAM-dependent toll-like receptor 4 signaling pathway [BP],
positive regulation of cellular glucuronidation [BP],
commissural neuron differentiation in spinal cord [BP],
ethanol binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_230_4 |
 |
 |
5 |
1.0 |
1.55E-04 |
VPS16,
GPT2,
SYTL1,
VPS18,
GPT |
L-alanine metabolic process [BP],
L-alanine catabolic process [BP],
HOPS complex [CC],
L-alanine:2-oxoglutarate aminotransferase activity [MF],
intracellular protein transport [BP] |
| CG_imr90ipsc_promoter_p_RM_12_185_3 |
 |
 |
1 |
0.2 |
1.02E-04 |
ZIC3 |
determination of left/right asymmetry in nervous system [BP] |
| CG_imr90ipsc_promoter_p_RM_12_195_6 |
 |
 |
6 |
1.0 |
1.24E-04 |
ESR1,
SOX11 |
positive regulation of lens epithelial cell proliferation [BP],
core promoter sequence-specific DNA binding [MF],
closure of optic fissure [BP],
positive regulation of hippo signaling cascade [BP],
estrogen-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_13_4 |
 |
 |
2 |
0.4 |
2.07E-04 |
TMEM126A,
NAV2 |
optic nerve development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_216_5 |
 |
 |
5 |
1.0 |
5.25E-04 |
GATA4,
AACS |
lung lobe formation [BP],
cellular response to glucose stimulus [BP],
acetoacetate-CoA ligase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_60_7 |
 |
 |
4 |
0.8 |
2.69E-04 |
APLP2,
FGF17,
THBS4,
OSR2,
GRN |
midbrain development [BP],
positive regulation of epithelial cell proliferation [BP],
growth factor activity [MF] |
| CG_imr90ipsc_promoter_p_RM_14_17_2 |
 |
 |
3 |
0.4 |
2.04E-04 |
PBX3 |
anterior compartment pattern formation [BP],
posterior compartment specification [BP] |
| CG_imr90ipsc_promoter_p_RM_12_142_4 |
 |
 |
5 |
1.0 |
3.88E-04 |
PAPOLA,
S100P,
MTHFD2,
ADSSL1 |
phosphate ion binding [MF],
magnesium ion binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_38_3 |
 |
 |
2 |
0.4 |
1.82E-04 |
ADRA2A |
phospholipase C-activating adrenergic receptor signaling pathway [BP],
negative regulation of adrenergic receptor signaling pathway [BP],
adenylate cyclase-inhibiting adrenergic receptor signaling pathway [BP] |
| CG_imr90ipsc_promoter_p_RM_16_2_5 |
 |
 |
11 |
1.0 |
5.01E-04 |
ACVR2A,
PRKCA,
UBE2R2,
MAST1,
BMPR2,
RBM20,
MAPKAPK2,
ABCG1 |
sterol-transporting ATPase activity [MF],
protein phosphorylation [BP],
nucleotide binding [MF],
protein serine/threonine kinase activity [MF],
positive regulation of pathway-restricted SMAD protein phosphorylation [BP],
activin-activated receptor activity [MF],
positive regulation of endothelial cell migration [BP],
transforming growth factor beta-activated receptor activity [MF],
protein kinase activity [MF],
vascular endothelial growth factor receptor signaling pathway [BP],
positive regulation of bone mineralization [BP],
transmembrane receptor protein serine/threonine kinase activity [MF],
response to lipid [BP],
ATP binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_193_7 |
 |
 |
5 |
1.0 |
3.04E-04 |
NLK,
CAT,
RBPJ,
RNF111,
SOX11 |
positive regulation of lens epithelial cell proliferation [BP],
blood vessel endothelial cell fate specification [BP],
positive regulation of BMP signaling pathway [BP],
menopause [BP],
cellular response to growth factor stimulus [BP],
positive regulation of ephrin receptor signaling pathway [BP],
positive regulation of hippo signaling cascade [BP],
transforming growth factor beta receptor signaling pathway [BP] |
| CG_imr90ipsc_promoter_p_RM_12_200_5 |
 |
 |
4 |
0.8 |
3.19E-04 |
KCNK3,
PLK4 |
open rectifier potassium channel activity [MF],
positive regulation of centriole replication [BP] |
| CG_imr90ipsc_promoter_p_RM_12_122_4 |
 |
 |
3 |
0.6 |
2.47E-04 |
ACADVL |
temperature homeostasis [BP] |
| CG_imr90ipsc_promoter_p_RM_14_11_7 |
 |
 |
7 |
1.0 |
4.96E-04 |
BMPR2,
CEBPB,
ACVR2A |
activin-activated receptor activity [MF],
transmembrane receptor protein serine/threonine kinase activity [MF],
transforming growth factor beta-activated receptor activity [MF],
positive regulation of osteoblast differentiation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_194_8 |
 |
 |
2 |
0.4 |
2.69E-04 |
TAB1,
UBC,
POU3F2 |
nucleotide-binding oligomerization domain containing signaling pathway [BP],
hypothalamus cell differentiation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_36_7 |
 |
 |
3 |
0.6 |
4.13E-04 |
PAX2,
NKD1 |
positive regulation of non-canonical Wnt receptor signaling pathway via JNK cascade [BP],
positive regulation of optic nerve formation [BP],
optic chiasma development [BP],
negative regulation of convergent extension involved in axis elongation [BP],
vestibulocochlear nerve formation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_214_3 |
 |
 |
6 |
0.8 |
3.20E-04 |
SOX9,
EPHB2 |
enhancer sequence-specific DNA binding [MF],
intrahepatic bile duct development [BP],
regulation of cell proliferation involved in tissue homeostasis [BP],
central nervous system projection neuron axonogenesis [BP],
corpus callosum development [BP],
epithelial cell proliferation involved in prostatic bud elongation [BP],
enhancer binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_107_9 |
 |
 |
4 |
0.8 |
3.41E-04 |
SQLE |
intracellular membrane-bounded organelle [CC] |
| CG_imr90ipsc_promoter_p_RM_12_11_6 |
 |
 |
4 |
0.8 |
2.17E-04 |
NAGS,
PLOD1 |
hydroxylysine biosynthetic process [BP],
acetyl-CoA:L-glutamate N-acetyltransferase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_62_4 |
 |
 |
4 |
0.8 |
3.24E-04 |
INHA |
inhibin A complex [CC] |
| CG_imr90ipsc_promoter_p_RM_12_132_4 |
 |
 |
3 |
0.6 |
3.66E-04 |
LPIN3,
SLC44A3 |
phosphatidylcholine biosynthetic process [BP] |
| CG_imr90ipsc_promoter_p_RM_12_149_5 |
 |
 |
3 |
0.6 |
2.13E-04 |
OGG1 |
8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF],
oxidized purine nucleobase lesion DNA N-glycosylase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_191_5 |
 |
 |
5 |
1.0 |
2.30E-04 |
YAP1,
FGF9 |
regulation of timing of cell differentiation [BP],
regulation of stem cell proliferation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_215_8 |
 |
 |
6 |
1.0 |
2.21E-04 |
PEX3,
ACSL3,
PEX26,
FOXB1,
MSX1 |
midbrain development [BP],
integral to peroxisomal membrane [CC],
protein import into peroxisome membrane [BP],
peroxisomal membrane [CC] |
| CG_imr90ipsc_promoter_p_RM_12_27_4 |
 |
 |
4 |
0.8 |
4.19E-04 |
GABARAPL2,
AHSA1 |
positive regulation of ATPase activity [BP] |
| CG_imr90ipsc_promoter_p_RM_12_25_4 |
 |
 |
5 |
1.0 |
3.90E-04 |
ETV2,
BUB3,
MIER1,
PRPF31,
FOXL1,
UNCX,
PRPF4B,
WRNIP1,
BANF2,
PCNT,
TBX4,
MAP2K4,
HEXDC,
ITGB3 |
olfactory bulb development [BP],
limb morphogenesis [BP],
nucleus [CC] |
| CG_imr90ipsc_promoter_p_RM_12_197_9 |
 |
 |
6 |
1.0 |
3.06E-04 |
CTCF,
VEGFA |
basophil chemotaxis [BP],
chromatin insulator sequence binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_202_7 |
 |
 |
2 |
0.4 |
3.37E-04 |
STAG3 |
transverse filament [CC] |
| CG_imr90ipsc_promoter_p_RM_14_2_1 |
 |
 |
2 |
0.4 |
1.10E-04 |
IFIT5,
SAFB,
DAZAP1 |
RNA binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_101_3 |
 |
 |
3 |
0.6 |
4.35E-04 |
TRAF2,
SKI,
HES1,
FOXB1 |
midbrain development [BP],
negative regulation of glial cell proliferation [BP],
embryo development [BP],
positive regulation of DNA binding [BP],
protein homotrimerization [BP] |
| CG_imr90ipsc_promoter_p_RM_12_223_4 |
 |
 |
2 |
0.4 |
8.31E-05 |
GREM1 |
negative regulation of bone mineralization involved in bone maturation [BP],
negative regulation of bone trabecula formation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_159_10 |
 |
 |
7 |
1.0 |
2.08E-04 |
RIMKLB,
RYR2 |
citrate-L-glutamate ligase activity [MF],
suramin binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_139_7 |
 |
 |
4 |
0.8 |
2.91E-04 |
HSPA6,
COPS4,
YAP1,
SOX9 |
positive regulation of epithelial cell differentiation [BP],
signalosome [CC],
notochord development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_210_2 |
 |
 |
4 |
0.8 |
3.10E-04 |
MPG,
RAD21L1 |
DNA-7-methylguanine glycosylase activity [MF],
DNA-7-methyladenine glycosylase activity [MF],
DNA-3-methylguanine glycosylase activity [MF],
DNA-3-methyladenine glycosylase activity [MF],
attachment of telomeric heterochromatin to nuclear envelope [BP] |
| CG_imr90ipsc_promoter_p_RM_12_23_9 |
 |
 |
3 |
0.6 |
2.76E-04 |
MPG,
ABHD5,
CAPN7 |
DNA-7-methylguanine glycosylase activity [MF],
DNA-7-methyladenine glycosylase activity [MF],
self proteolysis [BP],
lysophosphatidic acid acyltransferase activity [MF],
DNA-3-methylguanine glycosylase activity [MF],
DNA-3-methyladenine glycosylase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_18_14 |
 |
 |
4 |
0.8 |
4.70E-04 |
ETV2,
ITCH,
PRPF31 |
blood vessel morphogenesis [BP],
ribonucleoprotein complex binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_83_6 |
 |
 |
4 |
0.8 |
2.45E-04 |
USP10,
ZFYVE16,
ATP12A,
VPS16 |
hydrogen:potassium-exchanging ATPase complex [CC],
early endosome [CC] |
| CG_imr90ipsc_promoter_p_RM_12_212_5 |
 |
 |
5 |
1.0 |
2.47E-04 |
MSX2,
WWOX,
PLEKHA1,
SOX11,
HOXC10 |
osteoblast differentiation [BP],
skeletal system morphogenesis [BP],
positive regulation of BMP signaling pathway [BP],
negative regulation of transcription regulatory region DNA binding [BP],
skeletal system development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_199_4 |
 |
 |
2 |
0.4 |
1.46E-04 |
PIN1 |
phosphothreonine binding [MF],
phosphoserine binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_235_5 |
 |
 |
2 |
0.4 |
9.75E-05 |
CDKN1A,
IDUA,
PIGG,
TSEN34 |
CP2 mannose-ethanolamine phosphotransferase activity [MF],
tRNA-type intron splice site recognition and cleavage [BP],
cyclin-dependent protein kinase activating kinase activity [MF],
L-iduronidase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_105_5 |
 |
 |
3 |
0.6 |
2.47E-04 |
CACNA1C,
BMPR2,
DNAH14 |
regulation of vasoconstriction [BP],
caveolar macromolecular signaling complex [CC],
caveola [CC],
dynein complex [CC],
calcium-mediated signaling using extracellular calcium source [BP] |
| CG_imr90ipsc_promoter_p_RM_12_21_4 |
 |
 |
4 |
0.8 |
2.49E-04 |
SMAD6,
ID2,
GATA6,
PIAS4,
CDC45,
GTF2IRD2B,
HIST1H2BO,
PKNOX1,
SIM2 |
regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
embryonic pattern specification [BP],
negative regulation of transcription from RNA polymerase II promoter [BP],
negative regulation of transforming growth factor beta2 production [BP],
regulation of transcription, DNA-dependent [BP],
transcription, DNA-dependent [BP],
DNA binding [MF],
transcription from RNA polymerase II promoter [BP] |
| CG_imr90ipsc_promoter_p_RM_12_187_5 |
 |
 |
3 |
0.6 |
2.79E-04 |
PFKL |
6-phosphofructokinase complex [CC] |
| CG_imr90ipsc_promoter_p_RM_12_120_4 |
 |
 |
4 |
0.8 |
2.69E-04 |
UBE2D1,
RPL36,
MTX1,
RNF20,
GALNT2,
STUB1 |
ubiquitin conjugating enzyme complex [CC],
protein polyubiquitination [BP],
cellular protein metabolic process [BP] |
| CG_imr90ipsc_promoter_p_RM_12_127_4 |
 |
 |
5 |
1.0 |
2.03E-04 |
ULK1 |
radial glia guided migration of cerebellar granule cell [BP] |
| CG_imr90ipsc_promoter_p_RM_12_221_2 |
 |
 |
4 |
0.6 |
3.95E-04 |
SNRPD1,
ALG1,
ADARB1,
SNRNP35,
THRA,
PABPN1 |
chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF],
RNA binding [MF],
mRNA processing [BP],
U12-type spliceosomal complex [CC],
RNA splicing [BP],
RNA processing [BP],
regulation of thyroid hormone mediated signaling pathway [BP],
steroid receptor RNA activator RNA binding [MF],
nucleoplasm [CC] |
| CG_imr90ipsc_promoter_p_RM_14_18_2 |
 |
 |
2 |
0.4 |
1.60E-04 |
ARPC2 |
AP-1 adaptor complex binding [MF],
Arp2/3 complex binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_85_5 |
 |
 |
3 |
0.6 |
3.04E-04 |
RBL2,
SOX11,
FOXD3,
WEE1,
YAP1,
ZNF143 |
sympathetic nervous system development [BP],
nucleoplasm [CC],
hippo signaling cascade [BP],
regulation of stem cell proliferation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_110_5 |
 |
 |
4 |
0.8 |
2.59E-04 |
CTDP1,
POLR3E |
DNA-directed RNA polymerase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_189_4 |
 |
 |
4 |
0.8 |
2.49E-04 |
CTCF,
SNAI1 |
chromatin insulator sequence binding [MF],
negative regulation of cell differentiation involved in embryonic placenta development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_147_3 |
 |
 |
4 |
0.8 |
1.63E-04 |
PPARD,
STOX2,
YTHDC2 |
linoleic acid binding [MF],
maternal placenta development [BP],
nucleic acid binding [MF] |
| CG_imr90ipsc_promoter_p_RM_14_3_1 |
 |
 |
2 |
0.4 |
8.11E-05 |
CASP8 |
response to cobalt ion [BP],
Noc1p-Noc2p complex [CC] |
| CG_imr90ipsc_promoter_p_RM_12_225_8 |
 |
 |
4 |
0.8 |
2.53E-04 |
PIGG,
MAL,
FAM134A,
CREB3L4,
PAX2,
DLX4,
FKBP9,
HSD17B6,
BACE2 |
endoplasmic reticulum [CC],
transcription regulatory region DNA binding [MF],
sequence-specific DNA binding [MF],
transcription regulatory region sequence-specific DNA binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_33_8 |
 |
 |
3 |
0.6 |
2.58E-04 |
DACT1,
NR2E1,
HGSNAT,
GPX4 |
dendrite morphogenesis [BP],
heparan-alpha-glucosaminide N-acetyltransferase activity [MF],
amygdala development [BP],
phospholipid-hydroperoxide glutathione peroxidase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_116_2 |
 |
 |
3 |
0.6 |
3.00E-04 |
DYNC2H1,
CYR61,
SLC5A5,
DISP1 |
dorsal/ventral pattern formation [BP],
sodium:iodide symporter activity [MF],
intussusceptive angiogenesis [BP],
patched ligand maturation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_88_2 |
 |
 |
2 |
0.4 |
3.81E-04 |
SLC5A5,
MDK |
sodium:iodide symporter activity [MF],
defecation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_119_5 |
 |
 |
3 |
0.6 |
1.74E-04 |
WNT3A |
positive regulation of mesodermal cell fate specification [BP],
positive regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_87_7 |
 |
 |
5 |
1.0 |
2.58E-04 |
ZPBP2,
PVRL2 |
acrosome assembly [BP] |
| CG_imr90ipsc_promoter_p_RM_14_16_1 |
 |
 |
2 |
0.4 |
3.42E-04 |
EVX1,
MKL2,
SOX17,
MDK |
gall bladder development [BP],
cardiogenic plate morphogenesis [BP],
embryo development ending in birth or egg hatching [BP],
endodermal cell fate determination [BP],
short-term memory [BP],
positive regulation of transcription, DNA-dependent [BP],
heart morphogenesis [BP],
regulation of stem cell division [BP],
defecation [BP],
inner cell mass cellular morphogenesis [BP],
positive regulation of transcription from RNA polymerase II promoter [BP],
positive regulation of striated muscle tissue development [BP],
common bile duct development [BP],
regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification [BP],
stem cell fate specification [BP] |
| CG_imr90ipsc_promoter_p_RM_12_40_3 |
 |
 |
5 |
1.0 |
3.82E-04 |
CDC73,
USP47,
EVC,
RING1,
HEY2,
FOXG1,
LRRFIP1 |
positive regulation of smoothened signaling pathway [BP],
negative regulation of transcription, DNA-dependent [BP],
histone monoubiquitination [BP],
monoubiquitinated protein deubiquitination [BP] |
| CG_imr90ipsc_promoter_p_RM_12_37_4 |
 |
 |
8 |
1.0 |
4.58E-04 |
MAP3K3,
STK11,
GRK5 |
protein autophosphorylation [BP] |
| CG_imr90ipsc_promoter_p_RM_16_7_1 |
 |
 |
2 |
0.4 |
6.33E-04 |
PCDHA12,
PCDHA13,
PCDHA5,
PCDHA10 |
homophilic cell adhesion [BP],
calcium ion binding [MF],
cell adhesion [BP] |
| CG_imr90ipsc_promoter_p_RM_14_23_3 |
 |
 |
5 |
0.8 |
4.01E-04 |
CNNM2,
EIF3L,
ADHFE1,
MOCOS |
hydroxyacid-oxoacid transhydrogenase activity [MF],
Mo-molybdopterin cofactor sulfurase activity [MF],
molecular hydrogen transport [BP],
magnesium ion homeostasis [BP],
fibrillar center [CC] |
| CG_imr90ipsc_promoter_p_RM_12_203_3 |
 |
 |
5 |
0.8 |
1.71E-04 |
MCM4,
SLC25A37,
MCM5 |
MCM complex [CC],
DNA replication initiation [BP],
DNA strand elongation involved in DNA replication [BP],
mitochondrial iron ion transport [BP] |
| CG_imr90ipsc_promoter_p_RM_12_206_4 |
 |
 |
3 |
0.6 |
1.65E-04 |
NTN1,
DCC,
CACNA1G,
LAMP5,
SLC1A4,
MT1X |
negative regulation of growth [BP],
growth cone membrane [CC],
response to nickel cation [BP],
threonine transport [BP],
chloride transport [BP],
hydroxyproline transport [BP],
mammary gland duct morphogenesis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_124_4 |
 |
 |
5 |
1.0 |
1.03E-04 |
STK11 |
intrinsic apoptotic signaling pathway by p53 class mediator [BP] |
| CG_imr90ipsc_promoter_p_RM_12_129_4 |
 |
 |
3 |
0.6 |
1.99E-04 |
UGCG,
PDPK1 |
3-phosphoinositide-dependent protein kinase activity [MF],
ceramide glucosyltransferase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_14_7_4 |
 |
 |
7 |
1.0 |
3.78E-04 |
AATF,
SOX2 |
negative regulation of superoxide anion generation [BP],
detection of mechanical stimulus involved in equilibrioception [BP] |
| CG_imr90ipsc_promoter_p_RM_12_233_5 |
 |
 |
2 |
0.4 |
3.62E-04 |
NOG,
CNTNAP1,
UBA5,
HSD17B4,
ENGASE,
RAC3 |
very long-chain fatty-acyl-CoA metabolic process [BP],
negative regulation of cytokine activity [BP],
mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [MF],
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [MF],
17-beta-hydroxysteroid dehydrogenase (NAD+) activity [MF],
neuromuscular process controlling balance [BP],
UFM1 activating enzyme activity [MF] |
| CG_imr90ipsc_promoter_p_RM_14_10_5 |
 |
 |
5 |
0.6 |
5.11E-04 |
STOX2,
CEBPB,
GNAS,
ADORA2A |
embryo development [BP],
neuron differentiation [BP],
activation of adenylate cyclase activity [BP] |
| CG_imr90ipsc_promoter_p_RM_12_112_6 |
 |
 |
2 |
0.4 |
2.91E-04 |
BMPR1A,
ISL1 |
heart formation [BP],
endocardial cushion morphogenesis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_91_6 |
 |
 |
6 |
1.0 |
4.65E-04 |
RAB25,
ACTN3 |
pseudopodium membrane [CC],
pseudopodium [CC] |
| CG_imr90ipsc_promoter_p_RM_12_115_3 |
 |
 |
4 |
0.8 |
2.28E-04 |
ISG20 |
exoribonuclease II activity [MF] |
| CG_imr90ipsc_promoter_p_RM_16_1_2 |
 |
 |
11 |
1.0 |
4.50E-04 |
FUK,
GNAS,
PNPLA3 |
mono-olein transacylation activity [MF],
fucokinase activity [MF],
diolein transacylation activity [MF],
post-embryonic body morphogenesis [BP] |
| CG_imr90ipsc_promoter_p_RM_12_133_6 |
 |
 |
2 |
0.4 |
3.34E-04 |
NTRK2,
CARNS1 |
carnosine synthase activity [MF],
brain-derived neurotrophic factor-activated receptor activity [MF],
carnosine biosynthetic process [BP],
brain-derived neurotrophic factor receptor signaling pathway [BP],
brain-derived neurotrophic factor binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_196_7 |
 |
 |
5 |
1.0 |
2.71E-04 |
PCSK5,
TLR2 |
peptide biosynthetic process [BP],
embryonic digestive tract development [BP],
triacyl lipopeptide binding [MF],
cell surface pattern recognition receptor signaling pathway [BP],
induction by symbiont of defense-related host nitric oxide production [BP],
chloramphenicol transport [BP] |
| CG_imr90ipsc_promoter_p_RM_14_5_2 |
 |
 |
1 |
0.2 |
4.39E-04 |
HIST1H2BO,
HIST3H2BB,
B4GALNT3,
TNFRSF8 |
nucleosome assembly [BP],
positive regulation of TRAIL biosynthetic process [BP],
nucleosome [CC],
N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_16_3_1 |
 |
 |
5 |
0.6 |
4.76E-04 |
CDS2 |
phosphatidate cytidylyltransferase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_100_3 |
 |
 |
2 |
0.4 |
2.64E-04 |
SNRPD3,
CRAMP1L,
GSX2,
HOXC5,
RNASE2,
FOXF2,
ZNF646,
RNF4,
MAVS,
ZNF638 |
transcription, DNA-dependent [BP],
positive regulation of IP-10 production [BP],
DNA binding [MF],
RNA metabolic process [BP],
nucleic acid binding [MF] |
| CG_imr90ipsc_promoter_p_RM_16_5_1 |
 |
 |
3 |
0.6 |
3.45E-04 |
PVRL2,
HSPB8,
CD4 |
T cell differentiation [BP],
sperm mitochondrion organization [BP],
susceptibility to natural killer cell mediated cytotoxicity [BP],
coreceptor activity [MF],
induction by virus of host cell-cell fusion [BP],
entry into host cell [BP],
adhesion to symbiont [BP],
virion attachment, binding of host cell surface coreceptor [BP],
viral entry into host cell via membrane fusion with the plasma membrane [BP],
susceptibility to T cell mediated cytotoxicity [BP],
identical protein binding [MF],
protein palmitoleylation [BP] |
| CG_imr90ipsc_promoter_p_RM_14_14_5 |
 |
 |
13 |
1.0 |
5.36E-04 |
SOX8,
SOX12,
POU3F2 |
peripheral nervous system development [BP],
RNA polymerase II transcription coactivator activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_93_6 |
 |
 |
4 |
0.8 |
2.21E-04 |
RXRA |
ventricular cardiac muscle cell differentiation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_109_5 |
 |
 |
2 |
0.4 |
2.56E-04 |
PFAS,
OGDH |
oxoglutarate dehydrogenase (NAD+) activity [MF],
phosphoribosylformylglycinamidine synthase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_14_21_2 |
 |
 |
3 |
0.4 |
2.00E-04 |
ICAM1 |
response to sulfur dioxide [BP],
T cell antigen processing and presentation [BP] |
| CG_imr90ipsc_promoter_p_RM_14_12_2 |
 |
 |
8 |
1.0 |
4.22E-04 |
GNAI3,
DERA,
GNAS,
SLC27A4 |
mu-type opioid receptor binding [MF],
skin development [BP],
extrinsic to internal side of plasma membrane [CC],
post-embryonic body morphogenesis [BP],
G-protein beta/gamma-subunit complex binding [MF],
deoxyribose-phosphate aldolase activity [MF],
heterotrimeric G-protein complex [CC] |
| CG_imr90ipsc_promoter_p_RM_12_103_4 |
 |
 |
3 |
0.4 |
2.37E-04 |
MTO1,
YY1 |
mitochondrial tRNA wobble uridine modification [BP],
response to prostaglandin F stimulus [BP] |
| CG_imr90ipsc_promoter_p_RM_12_174_8 |
 |
 |
4 |
0.8 |
2.22E-04 |
PPP2R1A,
RALBP1,
PPP2R4,
NKD1 |
protein phosphatase type 2A regulator activity [MF],
ATPase activity [MF],
protein phosphatase type 2A complex [CC] |
| CG_imr90ipsc_promoter_p_RM_12_99_2 |
 |
 |
4 |
0.8 |
1.02E-04 |
SMYD2,
KIAA1967 |
RNA polymerase II core binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_34_6 |
 |
 |
4 |
0.8 |
2.72E-04 |
ITGB3,
RAP1B,
TIMP1,
F2R |
platelet activation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_137_4 |
 |
 |
4 |
0.8 |
3.44E-04 |
TLX3 |
neuron fate specification [BP] |
| CG_imr90ipsc_promoter_p_RM_12_97_6 |
 |
 |
7 |
1.0 |
2.77E-04 |
GATA4,
XRCC5,
MTA1,
TGIF1,
RNF10 |
sequence-specific DNA binding [MF],
co-SMAD binding [MF],
transcription regulatory region DNA binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_176_3 |
 |
 |
4 |
0.8 |
2.28E-04 |
PMPCB,
SMAD4,
TUBB,
THOP1,
ADAMTS16,
ABCG1 |
transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [MF],
sterol-transporting ATPase activity [MF],
detection of hormone stimulus [BP],
spindle assembly [BP],
metalloendopeptidase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_131_2 |
 |
 |
3 |
0.6 |
2.00E-04 |
UGCG,
PPP1CB,
MPP5,
WNT3A |
myosin phosphatase activity [MF],
myosin-light-chain-phosphatase activity [MF],
protein localization to myelin sheath abaxonal region [BP],
positive regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP],
ceramide glucosyltransferase activity [MF],
positive regulation of mesodermal cell fate specification [BP] |
| CG_imr90ipsc_promoter_p_RM_12_52_4 |
 |
 |
5 |
1.0 |
3.83E-04 |
OTC |
ornithine carbamoyltransferase complex [CC] |
| CG_imr90ipsc_promoter_p_RM_12_63_5 |
 |
 |
2 |
0.4 |
8.59E-05 |
SNX9,
ELMOD2,
TRPV2,
TRPM4 |
calcium channel activity [MF],
cation channel activity [MF],
positive regulation of GTPase activity [BP],
lipid tube assembly [BP] |
| CG_imr90ipsc_promoter_p_RM_12_118_4 |
 |
 |
4 |
0.8 |
2.52E-04 |
THBS1,
NOG |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [BP],
negative regulation of cytokine activity [BP],
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
negative regulation of cGMP-mediated signaling [BP],
negative regulation of nitric oxide mediated signal transduction [BP],
positive regulation of eukaryotic cell surface binding [BP],
negative regulation of dendritic cell antigen processing and presentation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_86_6 |
 |
 |
4 |
0.8 |
3.01E-04 |
SMARCA5 |
histone binding [MF] |
| CG_imr90ipsc_promoter_p_RM_14_4_2 |
 |
 |
3 |
0.6 |
1.25E-04 |
ZNF85,
ZNF493,
ZNF430,
ZNF431,
ZNF107,
ZNF714 |
DNA binding [MF],
zinc ion binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_164_7 |
 |
 |
5 |
1.0 |
2.20E-04 |
FOXL1,
DAND5 |
visceral mesoderm-endoderm interaction involved in midgut development [BP],
sequestering of nodal from receptor via nodal binding [BP] |
| CG_imr90ipsc_promoter_p_RM_12_186_6 |
 |
 |
5 |
1.0 |
5.30E-04 |
RSAD2,
PPP1R3G |
positive regulation of toll-like receptor 7 signaling pathway [BP],
positive regulation of toll-like receptor 9 signaling pathway [BP],
glycogen binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_218_7 |
 |
 |
4 |
0.8 |
1.80E-04 |
SPATA18 |
mitochondrion degradation by induced vacuole formation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_5_4 |
 |
 |
4 |
0.8 |
3.05E-04 |
OGG1,
ATIC |
dihydrofolate metabolic process [BP],
8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF],
oxidized purine nucleobase lesion DNA N-glycosylase activity [MF],
phosphoribosylaminoimidazolecarboxamide formyltransferase activity [MF],
IMP cyclohydrolase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_3_8 |
 |
 |
5 |
1.0 |
2.96E-04 |
YY1,
CCDC64 |
Golgi to secretory granule transport [BP],
response to prostaglandin F stimulus [BP] |
| CG_imr90ipsc_promoter_p_RM_12_180_6 |
 |
 |
2 |
0.4 |
1.97E-04 |
STUB1 |
positive regulation of chaperone-mediated protein complex assembly [BP] |
| CG_imr90ipsc_promoter_p_RM_12_123_2 |
 |
 |
1 |
0.2 |
1.94E-04 |
NF1 |
forebrain astrocyte development [BP] |
| CG_imr90ipsc_promoter_p_RM_12_114_5 |
 |
 |
5 |
0.8 |
2.17E-04 |
CHRNA7,
ISLR2,
PHAX,
CDKL5 |
toxin binding [MF],
positive regulation of axon extension [BP] |
| CG_imr90ipsc_promoter_p_RM_12_47_6 |
 |
 |
4 |
0.8 |
2.23E-04 |
NTMT1,
SETD6,
EHMT1 |
peptidyl-lysine monomethylation [BP],
protein methyltransferase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_9_5 |
 |
 |
3 |
0.6 |
2.78E-04 |
CABYR |
sperm fibrous sheath [CC] |
| CG_imr90ipsc_promoter_p_RM_12_108_3 |
 |
 |
3 |
0.6 |
3.16E-04 |
TRAFD1,
HIC1,
SEC24A,
BFAR,
PIAS4,
MSX1,
ZNF74,
ZNF397,
ZNF141 |
positive regulation of DNA damage response, signal transduction by p53 class mediator [BP],
zinc ion binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_92_3 |
 |
 |
5 |
1.0 |
2.53E-04 |
SIVA1,
NAGK,
KHK |
ketohexokinase activity [MF],
CD27 receptor binding [MF],
N-acetylglucosamine kinase activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_78_5 |
 |
 |
3 |
0.6 |
2.42E-04 |
UNC5A,
DYNC1H1,
PDPK1 |
cell death [BP],
regulation of apoptotic process [BP] |
| CG_imr90ipsc_promoter_p_RM_12_15_5 |
 |
 |
2 |
0.4 |
4.95E-04 |
ASXL1,
FOXQ1,
IL1R1,
GATA6 |
PR-DUB complex [CC],
interleukin-1, Type I, activating receptor activity [MF],
endodermal cell fate determination [BP],
negative regulation of transforming growth factor beta2 production [BP],
transcription factor binding [MF],
negative regulation of peroxisome proliferator activated receptor signaling pathway [BP],
negative regulation of transforming growth factor beta1 production [BP],
monoubiquitinated histone H2A deubiquitination [BP],
RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF] |
| CG_imr90ipsc_promoter_p_RM_12_8_6 |
 |
 |
4 |
0.8 |
3.61E-04 |
UTRN,
KIF26B,
ADAMTS13 |
ureteric bud invasion [BP],
integrin binding [MF] |
| CG_imr90ipsc_promoter_p_RM_14_22_2 |
 |
 |
2 |
0.4 |
2.55E-04 |
MFN2 |
blastocyst formation [BP] |
| CG_imr90ipsc_promoter_p_RM_14_19_3 |
 |
 |
4 |
0.6 |
3.17E-04 |
B4GALT7,
GNAS,
FKBP1B |
xylosylprotein 4-beta-galactosyltransferase activity [MF],
post-embryonic body morphogenesis [BP],
calcium channel complex [CC] |
| CG_imr90ipsc_promoter_p_RM_12_90_5 |
 |
 |
5 |
0.8 |
1.36E-04 |
FXN,
IL12A,
CLIC6 |
D4 dopamine receptor binding [MF],
iron chaperone activity [MF],
D2 dopamine receptor binding [MF],
regulation of ferrochelatase activity [BP],
interleukin-12 beta subunit binding [MF],
interleukin-27 binding [MF] |
| CG_imr90ipsc_promoter_p_RM_12_58_4 |
 |
 |
2 |
0.4 |
4.63E-04 |
RARA |
Sertoli cell fate commitment [BP] |
| CG_imr90ipsc_promoter_p_RM_12_84_2 |
 |
 |
2 |
0.4 |
4.89E-04 |
ZIC2 |
developmental pigmentation [BP] |
| CG_imr90ipsc_promoter_p_RM_12_41_5 |
 |
 |
2 |
0.4 |
3.79E-04 |
RFESD,
FXN |
2 iron, 2 sulfur cluster binding [MF] |
| CG_imr90ipsc_promoter_p_RM_14_1_2 |
 |
 |
3 |
0.6 |
6.35E-04 |
HIST1H2BO,
HIST1H2AH,
HIST1H2AC,
PIN1 |
nucleosome assembly [BP],
nucleosome [CC],
positive regulation of ubiquitin-protein ligase activity [BP],
protein heterodimerization activity [MF] |
| CG_imr90ipsc_promoter_p_RM_14_6_3 |
 |
 |
4 |
0.8 |
2.42E-04 |
PDPK1 |
3-phosphoinositide-dependent protein kinase activity [MF] |